Use of N terminal Pro Brain Natriuretic Peptide (NTproBNP) for assessment of risk of contrast induced nephropathy (CIN) in patients undergoing elective percutaneous coronary intervention (PCI)
2014 ◽
Vol 30
(12)
◽
pp. 1607-1612
◽
2015 ◽
Vol 66
(16)
◽
pp. C165-C166
2016 ◽
Vol 48
(10)
◽
pp. 1675-1682
◽
2014 ◽
Vol 64
(16)
◽
pp. C149